Frinnov Labs focuses on plant-derived CBD information shaped for everyday routines in Australia, with clarity ahead of hype. We keep language plain, avoid therapeutic claims, and emphasise transparent facts over speculation. No promises.
Our aim is to help Australians understand what a CBD actually offers, from lab documentation to labelling conventions. Where information isn’t published, we state it directly and keep a running record. Details remain limited.
We align content with Australian settings and current advertising restrictions, and we don’t discuss dosing, conditions, or diagnoses. You’ll find neutral explanations of categories, packaging, and access pathways used locally. We follow the rules.
Quality evidence sits at the heart of our approach, and we look for batch-level documentation before describing any claim. Certificates of Analysis, if available, should cover identity, potency, residual solvents, micro, and heavy metals. Proof matters.
Sourcing and manufacturing disclosures for Frinnov Labs are Not disclosed by brand, covering hemp origin, extraction method, and GMP status. Packaging details, shelf life, and stability data are likewise Not disclosed by brand at this time. Transparency builds trust.
Professional resources are reviewed in line with Australian expectations for pharmacist-only or prescriber pathways, without promotional language. Availability of HCP materials, clinical references, or access guides is Not disclosed by brand. Support should be clear.